Cargando…
Atorvastatin lowers serum calcium levels in lithium-users: results from a randomized controlled trial
BACKGROUND: Although lithium is considered the gold-standard treatment for bipolar disorder (BD), it is associated with a variety of major endocrine and metabolic side effects, including parathyroid hormone (PTH) dependent hypercalcemia. Aside from surgery and medication discontinuation, there are l...
Autores principales: | Soh, Jocelyn Fotso, Bodenstein, Katie, Yu, Oriana Hoi Yun, Linnaranta, Outi, Renaud, Suzane, Mahdanian, Artin, Su, Chien-Lin, Mucsi, Istvan, Mulsant, Benoit, Herrmann, Nathan, Rajji, Tarek, Beaulieu, Serge, Sekhon, Harmehr, Rej, Soham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508741/ https://www.ncbi.nlm.nih.gov/pubmed/36153583 http://dx.doi.org/10.1186/s12902-022-01145-w |
Ejemplares similares
-
Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trial
por: Fotso Soh, Jocelyn, et al.
Publicado: (2018) -
Obesity and metabolic comorbidity in bipolar disorder: do patients on lithium comprise a subgroup? A naturalistic study
por: Prillo, Jake, et al.
Publicado: (2021) -
Mindfulness-based intervention for benzodiazepine deprescription in hemodialysis patients with anxiety and depressive symptoms
por: Garel, Nicolas, et al.
Publicado: (2023) -
Time to Think “Meta”: A Critical Viewpoint on the Risks and Benefits of Virtual Worlds for Mental Health
por: Paquin, Vincent, et al.
Publicado: (2023) -
Virtual Healthcare for Older Adults: Accessibility, Perceptions and Benefits
por: Rigas, Christina, et al.
Publicado: (2023)